发明名称 Selectable cell surface marker genes
摘要 A method of identifying genetically modified mammalian cells comprising: a) introducing a nucleic acid sequence encoding a mutated protein-tyrosine kinase receptor (PTKR) operatively linked to an expression control sequence in to a cell to form a genetically modified cell, wherein the mutated PTKR either comprises a modification to the intracellular and the extracellular domains, or excludes any nerve growth factor receptors(s) (NGFR) and comprises a modification to the intracellular domain; b) allowing expression of the mutated PTKR in the genetically modified cell; and c) identifying said genetically modified cell expressing the mutated PTKR; provided that if the cell is human, the method is performed ex vivo. Also disclosed is the use of said method in the immunoselection of transduced mammalian cells, and mutated muscle specific tyrosine (MuSK-R) family members which are truncated in the cytoplasmic domain for use in said method.
申请公布号 NZ518877(A) 申请公布日期 2004.03.26
申请号 NZ20000518877 申请日期 2000.11.17
申请人 NOVARTIS AG 发明人 PIPPIG, SUSANNE DAGMAR;VERES, GABOR
分类号 G01N33/50;C07K14/705;C12N9/12;C12N15/09;C12Q1/02;G01N33/15;G01N33/53;G01N33/566;G01N33/569;(IPC1-7):C12Q1/00 主分类号 G01N33/50
代理机构 代理人
主权项
地址